Prostatis Group’s Schwab US Dividend Equity ETF SCHD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-15,298
Closed -$469K – 198
2026
Q1
$469K Buy
+15,298
New +$464K 0.12% 108
2023
Q3
– Sell
-197,337
Closed -$75.2K – 207
2023
Q2
$75.2K Buy
+197,337
New +$4.71M 0.04% 149

Other funds holding SCHD

Prostatis Group's SCHD Position: Q2 2026 in Review

Prostatis Group sold out of Schwab US Dividend Equity ETF (SCHD) in Q2 2026, closing a stake of 15,298 shares — an estimated $469K sold.

Prostatis Group first reported a position in SCHD in Q2 2023 and held it in 2 quarters. The position peaked at $469K in Q1 2026. 2,148 funds tracked by Wall St. Rank hold SCHD as of Q2 2026.

  • Prostatis Group reported no remaining Schwab US Dividend Equity ETF position as of Q2 2026 after selling out during the quarter.
  • Prostatis Group sold 15,298 Schwab US Dividend Equity ETF shares in Q2 2026, an estimated $469K.
  • Prostatis Group first reported a position in Schwab US Dividend Equity ETF in Q2 2023 and held it in 2 quarters.
  • Prostatis Group's Schwab US Dividend Equity ETF position peaked at $469K in Q1 2026.
  • 2,148 funds tracked by Wall St. Rank held Schwab US Dividend Equity ETF as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.